Australia's largest stock trading and investment forum Australia's #1 stock forum

OSP

Click for more information

0.00%

20.0¢ osprey medical inc

The supporting evidence will need to be gathered over a number...

First 14 Last

Share
Profile

Follow
sharetrader

654 Posts.

46

05/08/21

08:10

Post #: 55042555
Share

Originally posted by beaches811: ↑

I have the reverse opinion. They have really only been serious about sales and marketing for the past 5 months or so, it will take a full year for large results to be seen but they are making the right moves. They have created more sales support material in the past six months than the past 6 years from what I can see and this is what was wrong IMHO, things do not sell themselves, they need supporting evidence to convince people, the more supporting material (studies) the higher likelihood of a conversion. Covid in the short term is negative, in the long term it expands the Market due to kidney damage of covid patients. If they build a few studies showing the cost benefit I can see it being adopted across the board in countries where they have universal health as they are more cost conscious and would jump at proven methods to reduce costs and increase positive patient outcomes which is what is on offer here.

Expand

The supporting evidence will need to be gathered over a number of years, so while I have some skin in this game- they should have had something already running with strong supporters of the product ie hospital department who have core expertise so peer reviewed articles can be published. Hopefully GE can give some traction.

OSP Price at posting: 1.4¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?

TVN

Tivan and EARTH AI gear up to commence fresh drilling at Sandover lead-silver project, NT

RHI

Red Hill Minerals Signs $6.5 Million Agreement with Peel Mining to Explore Curnamona Project, NSW

KGL

KGL sniffs 19% Cu from drilling at Rockface play in NT

STN

Saturn’s stars have aligned for the gold explorer’s Apollo Project

Climate change to drive market trends to the moon

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

Week 27 Wrap: "Election year" is here as UK Labour win contrasts France; Trump wins immunity & annual report season hushes ASX

ITM

Fast-track assaying yields 182 g/t gold for iTech at new NT play

LLL

Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng

First 14 Last

Add OSP (ASX) to my watchlist